KENS 5: FDA bans red dye No. 3 in foods and medications. Here’s what to know.

January 16, 2025

David Gius, MD, PhD, assistant dean for research and professor, Department of Radiation Oncology, and associate cancer center director for translational research at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed for this news segment.   Watch Now (KENS 5) YouTube 

Early bumetanide restores social communication in fragile X, autism model

January 15, 2025

Research offers new insights for targeted, early interventions of autism spectrum disorder In a groundbreaking study published Dec. 24 in Genomic Psychiatry, scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and Hirosaki University successfully reversed abnormal social communication in a mouse model of fragile X syndrome using […]

Mirage News: New Book Offers Key Insights from Cancer in Latinos Conference

January 14, 2025

Amelie Ramirez, DrPH, MPH, professor and chair of the Department of Population Health Sciences, director of the department’s Institute for Health Promotion Research and associate director of Cancer Outreach and Engagement at the Mays Cancer Center, home to the UT Health San Antonio MD Anderson Cancer Center, was quoted in this article.   Read More

Medical Xpress: New book provides recommendations for addressing cancer among Latinos

January 14, 2025

Amelie Ramirez, DrPH, MPH, professor and chair of the Department of Population Health Sciences, director of the department’s Institute for Health Promotion Research and associate director of cancer outreach and engagement at the Mays Cancer Center, home to the UT Health San Antonio MD Anderson Cancer Center, was quoted in this article.   Read More